MassMutual Private Wealth & Trust’s Phathom Pharmaceuticals PHAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-427
Closed -$4.63K – 2447
2026
Q2
$4.63K Sell
427
-32
-7% -$365 ﹤0.01% 1715
2026
Q1
$5.1K Buy
459
+139
+43% +$1.76K ﹤0.01% 1670
2025
Q4
$5.31K Buy
320
+33
+11% +$471 ﹤0.01% 1654
2025
Q3
$3.38K Buy
+287
New +$2.96K ﹤0.01% 1821
2023
Q1
– Sell
-160
Closed -$2K – 1871
2022
Q4
$2K Buy
160
+132
+471% +$1.36K ﹤0.01% 1311
2022
Q3
$0 Buy
+28
New +$267 ﹤0.01% 1762

Other funds holding PHAT

MassMutual Private Wealth & Trust's PHAT Position: Q3 2026 in Review

MassMutual Private Wealth & Trust sold out of Phathom Pharmaceuticals (PHAT) in Q3 2026, closing a stake of 427 shares — an estimated $4.63K sold.

MassMutual Private Wealth & Trust first reported a position in PHAT in Q3 2022 and held it in 6 quarters. The position peaked at $5.31K in Q4 2025. 161 funds tracked by Wall St. Rank hold PHAT as of Q3 2026.

  • MassMutual Private Wealth & Trust reported no remaining Phathom Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 427 Phathom Pharmaceuticals shares in Q3 2026, an estimated $4.63K.
  • MassMutual Private Wealth & Trust first reported a position in Phathom Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • MassMutual Private Wealth & Trust's Phathom Pharmaceuticals position peaked at $5.31K in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q3 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2026, filed 5 Oct 2026.